At a Glance: Developing drugs in South Carolina

CHARLESTON, S.C. (AP) — A look at the impact of drug development and testing in South Carolina as contained in the report “Research in Your Backyard” released on Tuesday by the Pharmaceutical Research and Manufacturers of America, an industry trade group.

— Big bucks…

The industry contributes $2.4 billion in direct economic impact and $1.8 billion in indirect impacts to the state economy.

— …and a lot of jobs.

The industry supports about 4,800 direct jobs and 18,000 total jobs with workers earning an estimated $352 million.

— A lot of clinical trials…

Since 1999 there have been 3,200 clinical trials of new drugs statewide. About 1,700 of those have been tests of drugs targeting the nation’s six most debilitating chronic diseases: asthma, cancer, diabetes, heart disease, mental illness and stroke.

— …in a lot of places.

There are 290 clinical trials of drugs targeting the six most debilitating chronic diseases that are currently recruiting patients. Those trials are being conducted at health care facilities in Anderson, Charleston, Columbia, Easley, Greenville, Greer, Hilton Head, Mount Pleasant, Myrtle Beach, Orangeburg, Spartanburg, Summerville and Sumter.

Comments are closed.